1
|
Riddle L, James JE, Naeim A, Madlensky L, Brain S, DeRosa D, Eklund M, Fiscalini AS, Heditsian D, Koenig B, Ross K, Sabacan LP, Tong B, Wenger N, Joseph G. Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study. Public Health Genomics 2024; 27:177-196. [PMID: 39307132 DOI: 10.1159/000540680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2023] [Accepted: 07/30/2024] [Indexed: 11/12/2024] Open
Abstract
INTRODUCTION Risk-based breast cancer screening aims to address persistent high morbidity and mortality. This study examined the experience of participants in the Women Informed to Screen Depending on Measures of Risk (WISDOM) trial who received a pathogenic variant in one of nine high or moderate penetrance breast cancer genes. METHODS Participants completed a brief survey (n = 181) immediately following the results disclosure and 1 year later. Descriptive statistics were computed and comparisons between participants at different risk levels were performed using Fisher's exact and McNemar's tests. Analysis of qualitative interviews (n = 42) at 2-4 weeks and 6 months post-results disclosure compared responses at the 2 time points and explained and elaborated on the survey data. RESULTS 66.3% of survey respondents felt very or moderately prepared to receive genomic results. At the T1 survey, 80.7% of participants had shared the genetic result with a blood relative, increasing to 88.4% at T2; providing information and encouraging cascade testing were the most common reasons for sharing. Communication with a blood relative, other healthcare providers beyond the primary care provider, and cascade testing were higher for participants with a high risk than low or moderate risk genomic finding. Qualitative interviews elucidated varied reasons why participants felt (un)prepared for the results, including whether or not they had a family history of breast cancer, and illustrated the complexity of decision-making about sharing results. CONCLUSIONS Although most participants communicated results with family members and healthcare providers in accordance with their risk level, questions remain about how to adequately prepare individuals to receive pathogenic results, ensure timely and accessible follow-up care, and facilitate genetic counseling and cascade testing of at-risk relatives in the setting of population risk-based screening.
Collapse
Affiliation(s)
- Leslie Riddle
- Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA
| | | | - Arash Naeim
- Division of Hematology-Oncology, Center for SMART Health, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
| | - Lisa Madlensky
- Moores Cancer Center, Family Cancer Genetics Program, University of California, San Diego, California, USA
| | - Susie Brain
- Breast Science Advocacy Core, University of California, San Francisco, California, USA
| | - Diana DeRosa
- Moores Cancer Center, Family Cancer Genetics Program, University of California, San Diego, California, USA
| | - Martin Eklund
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden
| | | | - Diane Heditsian
- Breast Science Advocacy Core, University of California, San Francisco, California, USA
| | - Barbara Koenig
- Institute for Health and Aging, Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA
| | - Katherine Ross
- Cancer Genetics and Prevention Program, University of California, San Francisco, California, USA
| | - Leah P Sabacan
- Department of Surgery, University of California, San Francisco, California, USA
| | - Barry Tong
- Cancer Genetics and Prevention Program, University of California, San Francisco, California, USA
| | - Neil Wenger
- Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, California, USA
| | - Galen Joseph
- Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA
| |
Collapse
|
2
|
Martschenko DO, Wand H, Young JL, Wojcik GL. Including multiracial individuals is crucial for race, ethnicity and ancestry frameworks in genetics and genomics. Nat Genet 2023; 55:895-900. [PMID: 37202500 PMCID: PMC11506242 DOI: 10.1038/s41588-023-01394-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Current ontologies of race, ethnicity and genetic ancestry rely on categorization, but have limitations — as exemplified by multiracial individuals. We argue that including these individuals will foster inclusion by better capturing complex identities, with equity benefits for the full human population.
Collapse
Affiliation(s)
- Daphne O Martschenko
- Center for Biomedical Ethics, Department of Pediatrics, Stanford Medicine, Stanford, CA, USA
| | - Hannah Wand
- Department of Cardiology, Stanford Medicine, Stanford, CA, USA
| | - Jennifer L Young
- Center for Biomedical Ethics, Department of Pediatrics, Stanford Medicine, Stanford, CA, USA
- Center for Genetic Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
| | - Genevieve L Wojcik
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
| |
Collapse
|
4
|
Cheung ATM, Parent B. Mistrust and inconsistency during COVID-19: considerations for resource allocation guidelines that prioritise healthcare workers. JOURNAL OF MEDICAL ETHICS 2021; 47:73-77. [PMID: 33106381 DOI: 10.1136/medethics-2020-106801] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 09/29/2020] [Accepted: 10/06/2020] [Indexed: 06/11/2023]
Abstract
As the USA contends with another surge in COVID-19 cases, hospitals may soon need to answer the unresolved question of who lives and dies when ventilator demand exceeds supply. Although most triage policies in the USA have seemingly converged on the use of clinical need and benefit as primary criteria for prioritisation, significant differences exist between institutions in how to assign priority to patients with identical medical prognoses: the so-called 'tie-breaker' situations. In particular, one's status as a frontline healthcare worker (HCW) has been a proposed criterion for prioritisation in the event of a tie. This article outlines two major grounds for reconsidering HCW prioritisation. The first recognises trust as an indispensable element of clinical care and mistrust as a hindrance to any public health strategy against the virus, thus raising concerns about the outward appearance of favouritism. The second considers the ways in which proponents of HCW prioritisation deviate from the very 'ethics frameworks' that often preface triage policies and serve to guide resource allocation-a rhetorical strategy that may undermine the very ethical foundations on which triage policies stand. By appealing to trust and consistency, we re-examine existing arguments in favour of HCW prioritisation and provide a more tenable justification for adjudicating on tie-breaker events during crisis standards of care.
Collapse
Affiliation(s)
- Alexander T M Cheung
- Division of Medical Ethics, New York University School of Medicine, New York, New York, USA
| | - Brendan Parent
- Division of Medical Ethics, New York University School of Medicine, New York, New York, USA
| |
Collapse
|
5
|
Kraft SA, Garrison NA. An Ethical Case for Dual-Role Consent: Increasing Research Diversity as a Matter of Respect and Justice. THE AMERICAN JOURNAL OF BIOETHICS : AJOB 2019; 19:44-46. [PMID: 31544678 DOI: 10.1080/15265161.2019.1572816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- Stephanie A Kraft
- University of Washington School of Medicine and Seattle Children's Hospital and Research Institute
| | - Nanibaa' A Garrison
- University of Washington School of Medicine and Seattle Children's Hospital and Research Institute
| |
Collapse
|